The number of people suffering from diabetes is on the rise. Dietary means to lower postprandial glycemic responses are urgently needed for the prevention of type 2 Diabetes mellitus. Viscous dietary ﬁbers, including high molecular weight (HMW) oat beta-glucan, are one of the most effective classes of functional food ingredients for reducing postprandial glucose and so a potential solution. The mechanism of action is understood to be via an increase in viscosity of the stomach contents that delays gastric emptying and reduces the mixing of food with digestive enzymes. This, in turn, inhibits glucose absorption.
Setting the record straight for the crucial role of nutrition in the fight against cardiovascular disease
Cardiovascular disease (CVD) remains one of the biggest threats to human health and is a significant concern for medical and scientific communities globally. Currently, CVDs such as coronary heart disease (CHD) and stroke represent 31% of all global deaths, with an estimated 17.5 million people dying each year from the disease. It is the leading cause of death among both men and women in the US, and it is estimated that one in five adults in China has CVD, with the country having one of the highest CVD death rates in the world.
Today’s consumer is increasingly knowledgeable about their health, which has led to a rising interest in the influence of the ingredients in their diet. A recent consumer survey revealed that protection against diseases later in life – particularly cardiovascular conditions – is the leading health concern for adults of working age.
There are over 30,000 published scientific papers on omega-3 long chain polyunsaturated fatty acids, making them the most researched micronutrient in the world. Omega-3s are an essential part of daily nutrition, playing a critical role in supporting human health across different life stages. DHA (docosahexaenoic acid) provides important brain and eye health benefits, while EPA (eicosapentaenoic acid) and DHA together promote cardiovascular health.
At the heart of the matter: most comprehensive quantitative analysis of the effect of EPA and DHA on coronary heart disease
According to the World Health Organization, by 2030 almost 23.6 million people will die from cardiovascular diseases (CVDs) - mainly from coronary heart disease (CHD) and stroke, which are projected to remain the single leading causes of death. CHD is caused by a build-up of fatty deposits on the walls of the coronary arteries. A new comprehensive meta-analysis has been conducted to assess the effect of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) on CHD. The research also aims to estimate the association between EPA and DHA intake and CHD risk.